UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -6.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +4 | 28.21M | $15.29B | +8 | −3 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | — |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | — | — |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | — |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | — | — |
| Q2 2024 | 14 | — | 8.17M | $2.60B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passief) | 2.20M | — | $776.30M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 2.09M | -3.1% | $737.22M | 1.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 1.14M | +4.0% | $401.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.14M | +4.0% | $401.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 542.45K | -15.4% | $191.40M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 21 | Norges Bank ✦ (passief) | 430.12K | +1.5% | $151.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 397.88K | +15.5% | $140.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 397.88K | +15.5% | $140.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 107.73K | +74.5% | $38.01M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 61.18K | +17.5% | $21.59M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 43.29K | -16.0% | $15.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 43.29K | -16.0% | $15.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Millennium Management ✦ | 28.06K | +210.2% | $9.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 20.34K | Nieuw | $7.18M | 0.0% | New | 1 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 20.34K | Nieuw | $7.18M | 0.0% | New | 1 | SEC ↗ |
| 31 | Fisher Asset Management ✦ | 16.34K | +159.1% | $5.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 1.77K | +3.0% | $625,585 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $7.18M | 0.0% |
| Citadel Advisors | $7.18M | 0.0% |
Verlaten
| Marshall Wace | $4.55M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 218.70K aandelen, $129,684 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 1.32K aand · $675,421
Officer, Director · 3.59K aand · $1.84M
Officer, Director · 224 aand · $114,108
Officer, Director · 3.06K aand · $1.56M
Officer, Director · 1.30K aand · $669,921
Officer, Director · 773 aand · $399,695
Officer, Director · 235 aand · $123,474
Officer, Director · 455 aand · $238,247
Officer, Director · 669 aand · $349,411
Officer, Director · 271 aand · $139,254
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie